The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions
Abstract
Fractalkine is a unique chemokine reported to be constitutively expressed by neurons. Its only receptor, CX3CR1, is expressed by microglia. Little is known about the expression of fractalkine and CX3CR1 in spinal cord. Given that peripheral nerve inflammation and/or injury gives rise to neuropathic pain, and neuropathic pain may be partially mediated by spinal cord glial activation and consequent glial proinflammatory cytokine release, there must be a signal released by affected neurons that triggers the activation of glia. We sought to determine whether there is anatomical evidence implicating spinal fractalkine as such a neuron‐to‐glia signal. We mapped the regional and cellular localization of fractalkine and CX3CR1 in the rat spinal cord and dorsal root ganglion, under basal conditions and following induction of neuropathic pain, employing both an inflammatory (sciatic inflammatory neuropathy; SIN) as well as a traumatic (chronic constriction injury; CCI) model. Fractalkine immunoreactivity and mRNA were observed in neurons, but not glia, in the rat spinal cord and dorsal root ganglia, and levels did not change following either CCI or SIN. By contrast, CX3CR1 was expressed by microglia in the basal state, and the microglial cellular concentration was up‐regulated in a regionally specific manner in response to neuropathy. CX3CR1‐expressing cells were identified as microglia by their cellular morphology and positive OX‐42 and CD4 immunostaining. The cellular distribution of fractalkine and CX3CR1 in the spinal circuit associated with nociceptive transmission supports a potential role in the mechanisms that contribute to the exaggerated pain state in these models of neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,697
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 1×
“In contrast to many other chemokines, fractalkine binds only one receptor (CX3CR1) and its receptor binds only fractalkine (Jung et al., 2000; Hughes et al., 2002).”
BackgroundTripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 2×
“Upon activation by pathogens, neurotransmitters or neuromodulators, glia modulate neuronal excitability via the release of neuroactive substances, including proinflammatory cytokines, ATP, nitric oxide and excitatory amino acids (Araque et al., 1999; Konsman et al., 2002).”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Glial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,088
Self-citationCytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999 · cited 2×
“Upon activation by pathogens, neurotransmitters or neuromodulators, glia modulate neuronal excitability via the release of neuroactive substances, including proinflammatory cytokines, ATP, nitric oxide and excitatory amino acids (Araque et al., 1999; Konsman et al., 2002).”
BackgroundPathobiology of neuropathic pain
Zimmermann, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01303-6 · Cited by 937
Raghavendra, V., Tanga, F., & DeLeo, J. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797
Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats
Milligan, E. D., Twining, C., Chacur, M., Biedenkapp, J., O'Connor, K., Poole, S., Tracey, K., Martin, D., Maier, S. F., & Watkins, L. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01026.2003 · Cited by 701
Self-citationGLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 672
Self-citationImpaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
Abbadie, C., Lindia, J. A., Cumiskey, A. M., Peterson, L. B., Mudgett, J. S., Bayne, E. K., DeMartino, J. A., MacIntyre, D. E., & Forrest, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331358100 · Cited by 591
Tikka, T. M., & Koistinaho, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530
Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R., & Bacon, K. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1628 · Cited by 357
Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A., & Satoh, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00583-3 · Cited by 356
Chapman, G. A., Moores, K., Harrison, D., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 349
Chemokines in the CNS: plurifunctional mediators in diverse states
Asensio, V. C., & Campbell, I. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01453-8 · Cited by 345
The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat
Meller, S. T., Dykstra, C., Grzybycki, D., Murphy, S., & Gebhart, G. F. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90051-5 · Cited by 339
Colburn, R. W., DeLeo, J. A., Rickman, A. J., Yeager, M. P., Kwon, P., & Hickey, W. F. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00119-7 · Cited by 334
Milligan, E. D., O'Connor, K. A., Nguyen, K. T., Armstrong, C. B., Twining, C., Gaykema, R. P. A., Holguin, A., Martin, D., Maier, S. F., & Watkins, L. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02808.2001 · Cited by 317
Self-citationChacur, M., Milligan, E. D., Gazda, L. S., Armstrong, C., Wang, H., Tracey, K. J., Maier, S. F., & Watkins, L. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00354-2 · Cited by 309 · cited 6×
“Peri-sciatic injections of an immune activator (zymosan) were performed as detailed previously in order to induce enhanced nociception as a result of SIN (Chacur et al., 2001; Milligan et al., 2004).”
BackgroundMethodInfluentialSelf-citationMilligan, E. D., Mehmert, K. K., Hinde, J. L., Harvey, L. O., Martin, D., Tracey, K. J., Maier, S. F., & Watkins, L. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02050-3 · Cited by 279
Self-citationChemokines/chemokine receptors in the central nervous system and Alzheimer's disease
Xia, M., & Hyman, B. T. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029743 · Cited by 269
Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A., & Perry, V. H. (2002) · Glia · doi:10.1002/glia.10037 · Cited by 252
The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia
Boehme, S. A., Lio, F. M., Maciejewski-Lenoir, D., Bacon, K. B., & Conlon, P. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.397 · Cited by 192
Species heterogeneity in macrophage expression of the CD4 antigen.
Crocker, P. R., Jefferies, W. A., Clark, S. J., Chung, L.-P., & Gordon, S. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.2.613 · Cited by 110
Neuronal expression of fractalkine in the presence and absence of inflammation
Schwaeble, W., Stover, C. M., Schall, T. J., Dairaghi, D. J., Trinder, P. K. E., Linington, C., Iglesias, A. H., Schubart, A., Lynch, N. J., Weihe, E., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01384-2 · Cited by 107
Fractalkine protein localization and gene expression in mouse brain
Tarozzo, G., Bortolazzi, S., Crochemore, C., Chen, S. ‐., Lira, A. S., Abrams, J. S., & Beltramo, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10645 · Cited by 105
Gazda, L. S., Milligan, E. D., Hansen, M. K., Twining, C. M., Poulos, N. M., Chacur, M., O'Connor, K. A., Armstrong, C. B., Maier, S. F., Watkins, L. R., et al. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.006001111.x · Cited by 84
Self-citationSweitzer, S. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00036-x · Cited by 82
Rutkowski, M. D., Winkelstein, B. A., Hickey, W. F., Pahl, J. L., & DeLeo, J. A. (2002) · Spine · doi:10.1097/00007632-200208010-00003 · Cited by 70
Microglial proliferation in the spinal cord of aged rats with a sciatic nerve injury
Stuesse, S. L., Cruce, W. L. R., Lovell, J. A., McBurney, D. L., & Crisp, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01142-3 · Cited by 68
Response of Chemokine Antagonists to Inflammation in Injured Spinal Cord
Eng, L. F., & Lee, Y. L. (2003) · Neurochemical Research · doi:10.1023/a:1021652229667 · Cited by 28
Novel role of human CD4 molecule identified in neurodegeneration
Buttini, M., Westland, C. E., Masliah, E., Yafeh, A. M., Wyss‐Coray, T., & Mucke, L. (1998) · Nature Medicine · doi:10.1038/nm0498-441 · Cited by 28
Primary Cultures of Neonatal Rat Spinal Cord
Seybold, V. S., & Abrahams, L. G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:067 · Cited by 27
Milligan, E. D., Maier, S. F., & Watkins, L. R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:239 · Cited by 2
Self-citationZujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Cited by
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344
“For example, in the uninjured (normal) animal, the chemokine fractalkine (CX3CL1) is expressed by both primary afferents and spinal cord neurons (Lindia et al., 2005; Verge et al., 2004; Zhuang et al., 2007).”
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,732
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2533 · Cited by 1,399
Self-citationGlia and pain: Is chronic pain a gliopathy?
Ji, R.-R., Berta, T., & Nedergaard, M. (2013) · Pain · doi:10.1016/j.pain.2013.06.022 · Cited by 1,187
Metadata
- Authors
- Verge, G. M., Milligan, E. D., Maier, S. F., Watkins, L. R., Naeve, G. S., & Foster, A. C.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2004-09
- Volume
- 20
- Issue
- 5
- Pages
- 1150-1160
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2052193782
- Cited by
- 386
- References
- 38
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.